Skip to main content
SpringerLink
Log in

Oxalose Typ I im Kindesalter — Beobachtungen im Rahmen der terminalen Niereninsuffizienz beim Kind

Oxalosis type I in childhood — observations in chronic renal failure in the child

  • Case Reports
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The difficulties of biochemical diagnosis in children and in chronic renal failure are discussed in detail, as well as the development of diagnostic and therapeutic possibilities in recent years, exemplified by 4 cases.

Excretion of oxalate (and glycolate) may be incorrectly assumed to be normal with: a) uncritical application of the method of measurement, b) disregard of the clearly lower oxalate excretion in children (values should be referred to m2 of body surface), c) disregard of a decreased glomerular filtration rate (values should be referred to the creatinine clearance). With compromised renal function the excretion of oxalate and glycolate in primary oxalosis drops to “normal” whereas plasma values increase considerably. In this case the biochemical diagnosis is possible only by measurement of plasma values of glycolate and oxalate. Consequently, extensive extrarenal deposition of calcium oxalate crystals will, as a rule, become clinically manifest only after chronic renal failure has turned irreversible.

In recent years, several therapeutic procedures, have been developed. They are of therapeutic significance for the early stages of the disease as well. Observing especially conditions renal transplantation or combined hepatorenal transplantation can be managed with a successful outcome.

As the perioxisomal enzyme is activated only in the liver cells, an early liver transplantation as a definitive treatment by enzyme replacement may be the successful therapy in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

NI:

Niereninsuffizienz

KOF:

Körperoberfläche

NTP:

Nierentransplantation

AGT:

Alanin-Glyoxalat-Aminotransferase

Literatur

  1. Adams NC, Carrera GF, Johnson RP, Latorraca R, Leman J (1982) Calcium-oxalate-crystal-induced bone disease. Am J Kidney Dis 1:294–299

    Google Scholar 

  2. Akcay T, Rose GA (1980) The real and apparent oxalate in plasma. Clin Chim Acta 101:82–86

    Google Scholar 

  3. Alinei P, Guignard JP, Jaeger P (1984) Pyridoxine treatment of type I hyperoxaluria. N Engl J Med 311:798–799

    Google Scholar 

  4. Allsop J, Jennings PR, Danpure CJ (1987) A new microassay for human liver alanine: glyoxylate aminotransferase. Clin Chim Acta 170:187–194

    Google Scholar 

  5. Anderson DE, Davidson JK, Catto ME (1983) Case report 227. Skeletal Radiol 9:266–271

    Google Scholar 

  6. Balcke P, Schmidt P, Zazgornik J, Kopsa A, Deutsch E (1982) Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients. Eur J Clin Invest 12:481–483

    Google Scholar 

  7. Besio R, Meerhoff E, Laza J, Venturini A (1983) Oxalosis. Am J Ophthalmol 95:397–398

    Google Scholar 

  8. Breed A, Chesney R, Friedman A, Gilbert E, Langer L, Lattoraca R (1981) Oxalosis-induced bone disease: A complication of transplantation and prolonged survival in primary hyperoxaluria. J Bone Joint Surg (AM) 63-A:310–316

    Google Scholar 

  9. Brennan JN, Diwan RV, Makker SP, Cromer BA, Bellon EM (1982) Ultrasonic diagnosis of primary hyperoxaluria in infancy. Radiology 145:147–148

    Google Scholar 

  10. Boquist L, Lindqvist B, Ostberg Y, Steen L (1973) Primary oxalosis. Am J Med 54:673–681

    Google Scholar 

  11. Broyer M, Brunner FB, Rizzoni G, Brynger H, Fassbinder W, Selwood NH, Guillon PJ, Oulés R, Wing AJ, Challah S, Dykes SR (1986) Demography of Dialysis and Transplantation in Europe, 1984. Nephrol Dial Transpl 1:1–15

    Google Scholar 

  12. Broyer M (1988) Kidney transplantation in primary oxalosis (Abstract). Vth int. workshop on problems in renal insufficiency in children. Nieren- und Hochdruckkrankheiten 17:248

    Google Scholar 

  13. Bulla M (1980) Dialyse im Kindesalter. In: Renner E, Streicher E (Hrsg) Grenzen der Dialysebehandlung. Springer, Berlin Heidelberg New York, S 5–18

    Google Scholar 

  14. Chesney RW, Friedman AL, Breed AL (1984) Renal transplantation in primary oxaluria. J Pediatr 104:322–323

    Google Scholar 

  15. Constable AR, Joekes AM, Kasidas GP, O'Regan P, Rose GA (1979) Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both. Clin Sci 56:299–304

    Google Scholar 

  16. Crawhall JC, Watts RWE (1961) The oxalate content of human plasma. Clin Sci 20:357–366

    Google Scholar 

  17. Danpure CJ (1986) Peroxisomal alanine: glyoxylate aminotransferase and prenatal diagnosis of primary hyperoxaluria type I (letter). Lancet II:1168

    Google Scholar 

  18. Danpure CJ, Jennings PR (1986) Peroxisomal alanine: glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201:20–24

    Google Scholar 

  19. Danpure CJ, Jennings PR, Watts RWE (1987) Enzymological diagnosis of primary hyperoxaluria type I by measurement of hepatic alanine: glyoxylate aminotransferase activity. Lancet I:289–291

    Google Scholar 

  20. Danpure CJ, Jennings PR, Penketh RJ, Wise PJ, Rodeck CH (1988) Prenatal exclusion of primary hyperoxaluria type I. Lancet I:367

    Google Scholar 

  21. Dent CE, Stamp TC (1970) Treatment of primary hyperoxaluria. Arch Dis Child 45:735–745

    Google Scholar 

  22. Deodhar SD, Tung KSK, Zühlke V, Nakamoto S (1969) Renal homotransplantation in a patient with primary familial oxalosis. Arch Pathol 87:118–124

    Google Scholar 

  23. Desgrez P, David-Issartel R, Duburque MT, Charransol G (1975) État actuel du problème du dosage de l'acide oxalique dans le sang et les urines. In: Küss R, Legrain M (eds). Séminaires d'uro-néphrologie. Masson, Paris, pp 125–129

    Google Scholar 

  24. De Zegher FE, Wolff ED, von der Heijden J, Sukhai RN (1984) Oxalosis in infancy. Clin Nephrol 22:114–120

    Google Scholar 

  25. De Zegher FE, Przyrembel H, Chalmers RA, Wolff ED, Huijmans JG (1985) Successful treatment of infantile type I primary hyperoxaluria complicated by pyridoxine toxicity. Lancet II:392–393

    Google Scholar 

  26. Donckerwolcke RA, Kujiten RH, von Gol JD, Kramer PPG (1982) The treatment of primary hyperoxaluria with intermittent dialysis and transplantation. In: Bulla M (ed) Renal insufficiency in children. Springer, Berlin, Heidelberg, New York, pp 42–53

    Google Scholar 

  27. Fanconi A, Schneider A, Pfister L (1985) Früh erkannte und früh behandelte primäre Hyperoxalurie Typ I (Abstract). Helv Paediatr Acta 40:206

    Google Scholar 

  28. Fielder AR, Garner A, Chambers TL (1980) Ophthalmic manifestations of primary oxalosis. Br J Ophthalmol 64:782–788

    Google Scholar 

  29. Frederick EW, Rabkin MT, Richie RH, Smith LH (1963) Studies on primary hyperoxaluria I: In vivo demonstration of a defect glyoxylate metabolism. N Engl J Med 269:821–829

    Google Scholar 

  30. Furuta M, Torii S (1967) Congenital oxalosis: first report of two neonatal cases. Ann Pediatr Jpn 13:196

    Google Scholar 

  31. Gibbs DA, Watts RWE (1967) Biochemical studies on treatment of primary hyperoxaluria. Arch Dis Child 42:505–513

    Google Scholar 

  32. Gibbs DA, Watts RWE (1970) The action of pyridoxine in primary hyperoxyluria. Clin Sci 38:277–286

    Google Scholar 

  33. Gottlieb RP, Ritter JA (1977) “Flecked retina” — an association with primary hyperoxaluria. J Pediatr 90:939–942

    Google Scholar 

  34. Hall HE, Scowen EF, Watts RWE (1960) Clinical manifestations of primary hyperoxaluria. Arch Dis Child 35:108–112

    Google Scholar 

  35. Hallson PC, Rose GA (1974) A simplified and rapid enzymatic method for determination of urinary oxalate. Clin Chem Acta 55:29–39

    Google Scholar 

  36. Halverstadt DB, Wenzl JE (1974) Primary hyperoxaluria and renal transplantation. J Urol 111:398–402

    Google Scholar 

  37. Harrison AR, Kasidas GP, Rose GA (1981) Hyperoxaluria and recurrent stone formation apparently cured by short courses of pyridoxine. Brit Med J 1:2097–2098

    Google Scholar 

  38. Hockaday TDR, Clayton JE, Smith LH (1965) The metabolic error in primary hyperoxaluria. Arch Dis Child 40:485–491

    Google Scholar 

  39. Iancu TC, Danpure CJ (1987) Primary hyperoxaluria type I: ultrastructural observations in liver biopsies. J Inher Metab Dis 10:330–338

    Google Scholar 

  40. Jacobs C, Rottembourgh J, Reach I, Legrain M (1974) Terminal renal failure due to oxalosis in 14 patients. Proc Eur Dial Transplant Assoc 77:359–366

    Google Scholar 

  41. Jacobs C, Broyer M, Brunner FP, Brynger H, Donckerwolcke RA, Kramer P, Selwood SH, Wing AJ, Blake PH (1981) Combined report on regular dialysis and transplantation in Europe. IX, 1980. Proc Eur Dial Transpl Ass 18:4–58

    Google Scholar 

  42. Jacobsen E, Mosbek N (1974) Primary hyperoxaluria, treated with haemodialysis and kidney transplantation. Danish Med Bulletin 21:72–76

    Google Scholar 

  43. Jaeger Ph, Portmann L, Jacquet AF, Burckhardt P (1986) La pyridoxine peut normaliser l'oxalurie dans la lithiase rénale idiopathique. Schweiz Med Wochenschr 116:1783–1786

    Google Scholar 

  44. Kamoda N, Minatogawa J, Nakamura M, Nakamishi J, Okuno E, Kido R (1980) The organ distribution of human alanine-2-oxoglutarate aminotransferase and alanine-glyoxylate aminotransferase. Biochem Med 23:25–34

    Google Scholar 

  45. Kasidas GP, Rose GA (1979) A new enzymatic method for the determination of glycolate in urine and plasma. Clin Chem Acta 96:25–36

    Google Scholar 

  46. Kasidas GP, Rose GA (1984) Metabolic hyperoxaluria and its response to pyridoxine. In: Ryall RL, Brockis JG, Marshall VR, Finlayson B (eds) Urinary Stone. Proceedings of the 2nd International Urinary Stone Conference, Singapore, 1983. Churchill Livingstone, Melbourne, Edinburgh, London, New York, pp 138–147

    Google Scholar 

  47. Kasidas GP, Rose GA (1985) Continous flow assay for urinary oxalate using immobilised oxalate oxidase. Ann Clin Biochem 22:412–419

    Google Scholar 

  48. Kasidas GP, Rose GA (1986) Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase. Clin Chim Acta 154:49–58

    Google Scholar 

  49. Klauwers J, Wolff PL, Cohn R (1969) Failure of renal transplantation in primary oxalosis. JAMA: 209:551

    Google Scholar 

  50. Koch B, Irvine AH, Barr JR, Poznanski WJ (1972) Three kidney transplantations in a patient with primary hereditary hyperoxaluria. Can Med Ass J 106:1323–1327

    Google Scholar 

  51. Krouri A, Jacobs C, Charransol G, Clavel JP (1983) Renal clearance (RC) of oxalic acid in patients with chronic renal failure (CRF) and plasma oxalic acid (POA) in patients treated by maintenance hemodialysis (MH) and CAPD. Proc Eur Dial Transpl Ass 20:16

    Google Scholar 

  52. Latta K, Byrd D, Hoyer PF, Offner G (1987) Nierentransplantation bei Oxalose. Monatssch. Kinderheilkd 135:724

    Google Scholar 

  53. Leumann EP, Wegmann W, Largiadèr F (1978) Prolonged survival after renal transplantation in primary hyperoxaluria of childhood. Clin Nephrol 9:29–34

    Google Scholar 

  54. Leumann EP (1985) Primary hyperoxaluria: an important cause of renal failure in infancy. Int J Pediatr Nephrol 6:13–16

    Google Scholar 

  55. Leumann EP, Matasović A, Niederwieser A (1986) Primary hyperoxaluria type I: oxalate and glycolate unsuitable for prenatal diagnosis (letter). Lancet II:340

    Google Scholar 

  56. Leumann EP, Niederwieser A, Fanconi A (1987) New aspects of infantile oxalosis. Pediatr Nephrol 1:531–535

    Google Scholar 

  57. Lopez M, Tuchman M, Scheinman JI (1985) Capillary gas chromatography measurement of oxalate in plasma and urine. Kid Int 28:82–84

    Google Scholar 

  58. Ludwig GD (1963) Renal calculi associated with hyperoxaluria. Ann NY Acad Sci 104:621–637

    Google Scholar 

  59. Mathews M, Stauffer M, Cameron EC, Maloney N, Sherrard DJ (1979) Bone biopsy to diagnose hyperoxaluria in patients with renal failure. Ann Intern Med 90:777–779

    Google Scholar 

  60. Meredith TA, Wright JD, Gammon JA, Fellner SK, Warshaw BL, Maio M (1984) Ocular involvement in primary hyperoxaluria. Arch Ophthalmol 102:584–587

    Google Scholar 

  61. Morgan JM, Hartley MW, Miller AC, Diethelm AG (1974) Successful renal transplantation in hyperoxaluria. Arch Surg 109:430–433

    Google Scholar 

  62. Morgan SH, Purkiss P, Watts RWE, Mansell MA (1987) Oxalate dynamics in chronic renal failure: a comparison with normal subjects and patients with primary hyperoxaluria. Nephron 46:253–257

    Google Scholar 

  63. Morgan SH, Maher ER, Purkiss P (1988) Oxalate metabolism in end-stage renal disease. Nephrol Dial Transplant 3:28–32

    Google Scholar 

  64. Morgan SH, Watts RWE (1989) Perspectives in the assessment and management of patients with primary hyperoxaluria type I. Adv Nephrol 18:95–106

    Google Scholar 

  65. Morris MC, Chambers TL, Evans PW, Malleson PN, Pincott JR, Rose GA (1982) Oxalosis in infancy. Arch Dis Child 57:224–228

    Google Scholar 

  66. Niederwieser A, Matasović A, Leumann EP (1978) Glycolic acid in urine: a colorimetric method with values in normal adult controls and in patients with primary hyperoxaluria. Clin Chim Acta 89:13–23

    Google Scholar 

  67. Noguchi T, Takada Y (1979) Peroxisomal localization of alanine: glyoxylate aminotransferase in human liver. Arch Biochem Biophys 196:645–647

    Google Scholar 

  68. Prenen JAC, Mees EJD, Boer P, Endemann HJ, Ephraim KH (1979) Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper- and normo-oxaluric subjects. Proc Eur Dial Transpl Ass 16:566–571

    Google Scholar 

  69. Prenen JAC, Boer P, Mees EJD, Endemann HJ, Yoe OH (1981) Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Acta Med Scand 209:87–91

    Google Scholar 

  70. O'Regan P, Constable AR, Joekes AM, Kasidas GP, Rose GA (1980) Successful renal transplantation in primary hyperoxaluria. Postgrad Med J 56:288–293

    Google Scholar 

  71. Ramsay AG, Reed RG (1984) Oxalate removal by hemodialysis in end-stage renal disease. Am J Kidney Dis 4:123–127

    Google Scholar 

  72. Rizzoni G, Broyer M, Brunner FR, Brynger H, Challah S, Kramer P, Oulés R, Selwood NH, Wing AJ, Balás EA (1984) Combined report on regular dialysis and transplantation of children in Europe. XIII, 1983. Proc Eur Dial Transpl Ass 21:69–95

    Google Scholar 

  73. Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31–37

    Google Scholar 

  74. Rose GA, Arthur LJ, Chambers TL, Kasidas GP, Scott IV (1982) Successful treatment of primary hyperoxaluria in a neonate (letter). Lancet I:1298–1299

    Google Scholar 

  75. Saxon A, Busch GJ, Merrill JP, Franco V, Wilson RE (1974) Renal transplantation in primary hyperoxaluria. Arch Intern Med 133:464–466

    Google Scholar 

  76. Scheinman JI, Najarian JS, Mauer SM (1984a) Successful strategies for renal transplantation in primary oxalosis. Kid Int 25:804–811

    Google Scholar 

  77. Scheinman JI, Gale D, Roe CR, Millington DS (1984b) Reliable measurement of urine and plasma oxalate by gas chromatography and mass spectrometry. Kid Int (letter) 28:126

    Google Scholar 

  78. Scowen EF, Watts RWE, Hall EG (1979) Further observations on the genetic basis of primary hyperoxaluria. Ann Hum Genet 23:367–381

    Google Scholar 

  79. Silver L, Brendler H (1971) Use of magnesium oxide in management of familial hyperoxaluria. J Urol 106:274–279

    Google Scholar 

  80. Smith LH, Hockaday TDR, Efron ML, Clayton JE (1964) The metabolic defect of primary hyperoxaluria. Trans Assoc Am Physicians 77:317–325

    Google Scholar 

  81. Smith LH (1976) Application of physical, chemical, and metabolic factors to the management of urolithiasis. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis Research. Plenum Medical Book Company, New York, pp 199–211

    Google Scholar 

  82. Solomons CC, Goodman SI, Riley CM (1967) Calcium carbimide in the treatment of primary hyperoxaluria. N Engl J Med 276:207–210

    Google Scholar 

  83. Takada Y, Mori T, Noguchi T (1984) The effect of vitamin B6 deficiency on alanine:glyoxalate aminotransferase isoenzymes in rat liver. Arch Biochem Biophys 229:1–6

    Google Scholar 

  84. Toussaint C, Goffin Y, Potvliege P, Dupuis F, Dupont E, Toussaint D, Kinnaert P, van Geertruyden G, Vereerstraeten P (1976) Kidney transplantation in primary oxalosis. Clin Nephrol 5:239–244

    Google Scholar 

  85. Watts RWE, Chalmers RA, Gibbs DA, Lawson AM, Purkiss P, Spellacy E (1979) Studies on some possible biochemical treatments of primary hyperoxaluria. Quart J Med 48:259–272

    Google Scholar 

  86. Watts RWE, Veall N, Purkiss P (1983) Sequential studies of oxalate dynamics in primary hyperoxaluria. Clin Sci 65:627–633

    Google Scholar 

  87. Watts RWE, Veall N, Purkiss P (1984) Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Clin Sci 66:591–597

    Google Scholar 

  88. Watts RWE, Veall N, Purkiss P, Haywood EF (1985) The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (with glycolic aciduria). Clin Sci 69:87–90

    Google Scholar 

  89. Watts RWE, Calne RY, Williams R, Mansell MA, Purkiss P, Rolles K (1985b) Primary hyperoxaluria type I: attempted treatment by combined hepatic and renal transplantation. Quart J Med 57:697–703

    Google Scholar 

  90. Watts RWE, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, Williams R, Purkiss P (1987) Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet I:474–475

    Google Scholar 

  91. Watts RWE, Morgan SH, Purkiss P (1988) Timing of renal transplantation in the management of pyridoxine resistant type I primary hyperoxaluria. Transplantation 45:1143–1145

    Google Scholar 

  92. Whelchel JD, Alison DV, Luke RG, Curtis J, Diethelm AG (1983) Successful renal transplantation in hyperoxaluria. Transplantation 35:161–164

    Google Scholar 

  93. Will EJ, Bijvoet OL (1979) Primary oxalosis: clinical and biochemical response to high-dose pyridoxine therapy. Metabolism 28:542–548

    Google Scholar 

  94. Williams HE, Smith LH (1983) Primary hyperoxaluria. In: Stanbury JB, Wyngaarden JB, Frederickson DS (eds). The metabolic basis of inherited diseases. McGraw Hill, New York, pp 182–204

    Google Scholar 

  95. Wilson DA, Wenzl JE, Altshuler GP (1979) Ultrasound demonstration of diffuse cortical nephrocalcinosis in a case of primary hyperoxaluria. Am J Roentgenol 132:659–661

    Google Scholar 

  96. Wise PJ, Danpure CJ, Jennings PR (1987) Immunological heterogenity of hepatic alanine: glyoxylate aminotransferase in primary hyperoxaluria type I. FEBS Lett 222:17–20

    Google Scholar 

  97. Wolthers BG, Hayer M (1982) The determination of oxalic acid in plasma and urine by means of capillary gas chromatography. Clin Chim Acta 120:87–102

    Google Scholar 

  98. Yendt ER, Cohanim M (1985) Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria. N Engl J Med 312:953–957

    Google Scholar 

  99. Zak TA, Buncic R (1983) Primary hereditary oxalosis retinopathy. Arch Ophthalmol 101:78–80

    Google Scholar 

  100. Zarembsky RM, Hodgkinson A (1966) Elevation of the concentration of plasma oxalic acid in renal failure. Nature 212:511–512

    Google Scholar 

  101. Zerwekh JE, Drake E, Gregory J, Griffith D, Hofmann AF, Menon M, Pak CYC (1983) Assay of urinary oxalate: six methodologies compared. Clin Chem 29:1977–1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kinderklinik der Westfälischen Wilhelms-Universität Münster, Germany

    M. Frosch, E. Kuwertz-Bröking & M. Bulla

  2. Gerhard-Domagk-Institut für Pathologie der WWU Münster, Germany

    D. -B. von Bassewitz

  3. Urologische Klinik der WWU Münster, Germany

    D. B. Leusmann

Authors
  1. M. Frosch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Kuwertz-Bröking
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Bulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. -B. von Bassewitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. B. Leusmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frosch, M., Kuwertz-Bröking, E., Bulla, M. et al. Oxalose Typ I im Kindesalter — Beobachtungen im Rahmen der terminalen Niereninsuffizienz beim Kind. Klin Wochenschr 67, 1156–1167 (1989). https://doi.org/10.1007/BF01726118

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01726118

Key words

Search

Navigation